Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China
Abstract The prevalence and antithrombotic treatment of atrial fibrillation (AF) in Chinese rural population is not well known. The aim of this study was to investigate the extent to which antithrombotic treatment was prescribed for rural AF patients >60 years. We identified 828 AF patients from...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6a0d66adb4d24f04bcc5638703223322 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:6a0d66adb4d24f04bcc5638703223322 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:6a0d66adb4d24f04bcc56387032233222021-12-02T12:31:56ZSurvey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China10.1038/s41598-018-24878-y2045-2322https://doaj.org/article/6a0d66adb4d24f04bcc56387032233222018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-24878-yhttps://doaj.org/toc/2045-2322Abstract The prevalence and antithrombotic treatment of atrial fibrillation (AF) in Chinese rural population is not well known. The aim of this study was to investigate the extent to which antithrombotic treatment was prescribed for rural AF patients >60 years. We identified 828 AF patients from 36734 rural residents >60 years in Shanghai China. Our data indicated the overall prevalence rate of AF was 2.3% in rural population >60 years in East China and 38.9% of AF patients underwent antithrombotic therapy, including warfarin (5.9%), aspirin (29.6%), clopidogrel (2.9%) and aspirin combined with clopidogrel (0.5%). Of enrolled subjects, 98.4% had CHA2DS2-VASc score ≥1, 72.0% had HAS-BLED score <3 and 59.2% had CHA2DS2-VASc score ≥2 with HAS-BLED score <3. Missing early detection (34.9%), delay in seeking treatment for asymptomatic AF (25.5%) and doctors’s incomplete inform of AF-related risk of stroke to patients (21.7%) were three dominant causes for failing anticoagulant usage. In conclusion, most AF patients were with a high risk of thrombosis and a low risk of bleeding in China, but a large majority of them failed to take anticoagulants mainly for missing an early screening of AF and lack of awareness on AF for both patients and primary care physicians.Yong WeiJuan XuHaiqing WuGenqing ZhouSongwen ChenCaihong WangYahong ShenShunhong YangBin WangZheng HeJianping SunWeidong SunPing OuyangShaowen LiuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-8 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yong Wei Juan Xu Haiqing Wu Genqing Zhou Songwen Chen Caihong Wang Yahong Shen Shunhong Yang Bin Wang Zheng He Jianping Sun Weidong Sun Ping Ouyang Shaowen Liu Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China |
| description |
Abstract The prevalence and antithrombotic treatment of atrial fibrillation (AF) in Chinese rural population is not well known. The aim of this study was to investigate the extent to which antithrombotic treatment was prescribed for rural AF patients >60 years. We identified 828 AF patients from 36734 rural residents >60 years in Shanghai China. Our data indicated the overall prevalence rate of AF was 2.3% in rural population >60 years in East China and 38.9% of AF patients underwent antithrombotic therapy, including warfarin (5.9%), aspirin (29.6%), clopidogrel (2.9%) and aspirin combined with clopidogrel (0.5%). Of enrolled subjects, 98.4% had CHA2DS2-VASc score ≥1, 72.0% had HAS-BLED score <3 and 59.2% had CHA2DS2-VASc score ≥2 with HAS-BLED score <3. Missing early detection (34.9%), delay in seeking treatment for asymptomatic AF (25.5%) and doctors’s incomplete inform of AF-related risk of stroke to patients (21.7%) were three dominant causes for failing anticoagulant usage. In conclusion, most AF patients were with a high risk of thrombosis and a low risk of bleeding in China, but a large majority of them failed to take anticoagulants mainly for missing an early screening of AF and lack of awareness on AF for both patients and primary care physicians. |
| format |
article |
| author |
Yong Wei Juan Xu Haiqing Wu Genqing Zhou Songwen Chen Caihong Wang Yahong Shen Shunhong Yang Bin Wang Zheng He Jianping Sun Weidong Sun Ping Ouyang Shaowen Liu |
| author_facet |
Yong Wei Juan Xu Haiqing Wu Genqing Zhou Songwen Chen Caihong Wang Yahong Shen Shunhong Yang Bin Wang Zheng He Jianping Sun Weidong Sun Ping Ouyang Shaowen Liu |
| author_sort |
Yong Wei |
| title |
Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China |
| title_short |
Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China |
| title_full |
Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China |
| title_fullStr |
Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China |
| title_full_unstemmed |
Survey of Antithrombotic Treatment in Rural Patients (>60 years) with Atrial Fibrillation in East China |
| title_sort |
survey of antithrombotic treatment in rural patients (>60 years) with atrial fibrillation in east china |
| publisher |
Nature Portfolio |
| publishDate |
2018 |
| url |
https://doaj.org/article/6a0d66adb4d24f04bcc5638703223322 |
| work_keys_str_mv |
AT yongwei surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT juanxu surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT haiqingwu surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT genqingzhou surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT songwenchen surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT caihongwang surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT yahongshen surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT shunhongyang surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT binwang surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT zhenghe surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT jianpingsun surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT weidongsun surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT pingouyang surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina AT shaowenliu surveyofantithrombotictreatmentinruralpatients60yearswithatrialfibrillationineastchina |
| _version_ |
1718394218717642752 |